ACTSI Investigator Dr. Stephen Warren in the News

Stephen Warren, PhD, FACMG, ACTSI investigator, William Patterson Timmie Professor of Human Genetics, Charles Howard Candler Chair in Human Genetics, Chairman of the Department of Human Genetics
Professor, Biochemistry and Pediatrics, Emory University School of Medicine

Lab Land | Fragile X regulation is a finely tuned machine
November 10, 2015

Emory News Center | Four Emory faculty named to American Academy of Arts and Science
April 22, 2015

Lab Land | Point mutation in fragile X gene reveals separable functions in brain
January 5, 2015

Emory News Center | NIH Awards Emory Genetics Team $9 million for Fragile X syndrome research center
October 3, 2014

Warren received the Association for Molecular Pathology's Award for Excellence in Molecular Diagnostics. | NIH Awards $35 Million for Centers for Collaborative Research in Fragile X
September 23, 2014

CNN Health | Parents push for standardized screening of Jewish genetic diseases
September 10, 2013

Genome Web | Emory to lead genome sequencing effort for psychiatric disorders research project
October 2, 2013

Emory News Center | International consortium receives NIH grant to study genetics of schizophrenia
October 1, 2013

Atlanta Business Chronicle | Emory seeks patent on autism treatment
July 25, 2013

Lab Land | Fragile X clinical trials: this is not the end
June 11, 2013

7th annual Celebration of Technology and Innovation awardee (March 2012) - Seaside Therapeutics teamed with Roche on development of treatments for fragile X syndrome and autism spectrum disorders (Stephen Warren, human genetics)

ACTSI Investigator Dr. Stephen Warren in the News 2012-2013